| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.094 | 0.04 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.083 | 0.05 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.081 | 0.08 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.07 | 0.1 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.07 | 0.1 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.061 | 0.2 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.065 | 0.2 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.062 | 0.2 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.041 | 0.4 |